FDA PMA
FDA Class 3
Approved
🇺🇸 United States
System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection
PMA: P230043
·
Supplement: S007
·
Decision Jun 2, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0
Basic Information
- Device Name
- System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection
- Trade Name
- Cologuard Plus
- PMA Number
- P230043
- Supplement Number
- S007
- Device Class
- FDA Class 3
- Product Code
- PHP
- Generic Name
- System, colorectal neoplasia, DNA methylation and hemoglobin detection
- Medical Specialty
- Unknown
- Advisory Committee
- Pathology
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- June 2, 2026
- Date Received
- March 6, 2026
- Supplement Type
- Real-Time Process
- Supplement Reason
- Change Design/Components/Specifications/Material
- Expedited Review
- N
Advisory Committee Statement
Approval to use a new Class I instrument, referred to as the Capture Aspiration Module (CAM), in the laboratory workflow of the Cologuard Plus test.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| PHP | System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection | FDA class 3 | Unknown |